All IL13(E12Y)-CAR T cell variants mediated effective elimination of GBM cells until day 3 (i.e., after a single GBM rechallenge, total E:T = 1:12), again supporting their capacity to recursively kill. This evidence concerns the gene IL13 and glioblastoma.